Page last updated: 2024-11-05

trapidil and Coronary Restenosis

trapidil has been researched along with Coronary Restenosis in 9 studies

Trapidil: A coronary vasodilator agent.

Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Research Excerpts

ExcerptRelevanceReference
"We hypothesize that the utilization of trapidil-eluting DES in the setting of acute coronary syndromes will be characterized by a greater early re-endothelialization associated with an antiproliferative effect offering a similar efficacy with a better safety profile compared with first-generation DES."9.14Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-e ( Iaccarino, D; Modena, MG; Monopoli, D; Politi, L; Rossi, R; Sangiorgi, GM; Sgura, F, 2010)
"We hypothesize that the utilization of trapidil-eluting DES in the setting of acute coronary syndromes will be characterized by a greater early re-endothelialization associated with an antiproliferative effect offering a similar efficacy with a better safety profile compared with first-generation DES."5.14Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-e ( Iaccarino, D; Modena, MG; Monopoli, D; Politi, L; Rossi, R; Sangiorgi, GM; Sgura, F, 2010)
"Aspirin was given to all patients, and ticlopidine 250 mg b."2.71Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting. ( Balducelli, M; Barlera, S; Bernardi, G; Latini, R; Maggioni, AP; Maresta, A; Moccetti, T; Monici Preti, A; Ribeiro da Silva, EE; Sosa, C; Varani, E, 2005)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's7 (77.78)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khan, M1
Mhulláin, FN1
Nolan, M1
Iaccarino, D1
Politi, L1
Rossi, R1
Sgura, F1
Monopoli, D1
Modena, MG1
Sangiorgi, GM1
Okamoto, S1
Nakano, T1
Kitai, T1
Ishiwata, S1
Yamaguchi, T1
Maresta, A1
Balducelli, M1
Latini, R1
Bernardi, G1
Moccetti, T1
Sosa, C1
Barlera, S1
Varani, E1
Ribeiro da Silva, EE1
Monici Preti, A1
Maggioni, AP1
Douglas, JS1
Murphy, JG1
Serruys, PW1
Foley, DP1
Pieper, M1
Kleijne, JA1
de Feyter, PJ1

Reviews

4 reviews available for trapidil and Coronary Restenosis

ArticleYear
Intrepide; Trapidil eluting stent.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2008, Volume: 4, Issue:3

    Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents;

2008
[Clinical trials of restenosis after PTCA and QOL of patients after PTCA].
    Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52 Suppl, Issue:Pt 1

    Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Atherectom

1994
[Prevention of postangioplasty restenosis].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 4

    Topics: Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Clinical Trials as Topic; Coated Materials, B

2003
Pharmacologic approaches to restenosis prevention.
    The American journal of cardiology, 2007, Sep-03, Volume: 100, Issue:5A

    Topics: Angioplasty, Balloon, Coronary; Cilostazol; Coated Materials, Biocompatible; Coronary Artery Disease

2007

Trials

3 trials available for trapidil and Coronary Restenosis

ArticleYear
Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-e
    Journal of cardiovascular medicine (Hagerstown, Md.), 2010, Volume: 11, Issue:7

    Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Biomarkers; Cardiac Catheterization; Cardio

2010
Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2005, Volume: 64, Issue:3

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiography;

2005
The TRAPIST Study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound.
    European heart journal, 2001, Volume: 22, Issue:20

    Topics: Aged; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Coronary Angiography; Coronar

2001

Other Studies

2 other studies available for trapidil and Coronary Restenosis

ArticleYear
A monk's prayer: O Lord what is the answer to in-stent restenosis? Commentary on the TRAPIST Study.
    European heart journal, 2001, Volume: 22, Issue:20

    Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Cor

2001
[Balloon dilatation plus PDGF antagonist. With this coronary arteries remain patent].
    MMW Fortschritte der Medizin, 2001, Oct-18, Volume: 143, Issue:42

    Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; H

2001